GENERIC IMATINIB: A AFFORDABLE OPTION?

The emergence of generic imatinib represents a significant chance for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, often referred to as Gleevec, carries a steep price cost, frequently causing accessibility for some individuals. Common versions, usua